Home » News » Announcements
Feb 27, 2013, 11.51 AM IST | Source: Moneycontrol.com

Fresenius Kabi puts production of West Bengal API plant on hold

During a recent routine inspection USFDA made certain observations relating to GMP non-conformities in respect of manufacturing, documentation practices and product testing. The Company has immediately taken steps to implement remedial measures and has voluntarily put the production on hold at Kalyani, District Nadia, West Bengal, (India).

Fresenius Kabi Oncology Ltd has informed BSE that during a recent routine US FDA inspection at Company’s API plant located at Kalyani, District Nadia, West Bengal, (India), US FDA made certain observations relating to GMP non-conformities in respect of manufacturing, documentation practices and product testing. However, all finished products conform to approved standards and specifications.The Company has immediately taken steps to implement remedial measures and has voluntarily put the production on hold. The Company’s dosage form plants in Himachal Pradesh continue normal production.Source : BSE

Read all announcements in Fresenius Kabi

Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Narendra Modi

99374.06 2,015.63 2.07%

1110

Bought today

1282

Sold today

0.96%

User holding

video of the day

Add cyclicals, banks on positive poll outcome: UBS

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.